| Autor: |
Hausleiter, Jörg, Kastrati, Adnan, Wessely, Rainer, Dibra, Alban, Mehilli, Julinda, Schratzenstaller, Thomas, Graf, Isolde, Renke-Gluszko, Magdalena, Behnisch, Boris, Dirschinger, Josef, Wintermantel, Erich, Schömig, Albert |
| Zdroj: |
European Heart Journal; Aug2005, Vol. 26 Issue 15, p1475-1481, 7p |
| Abstrakt: |
Aims Drug-eluting stents (DES) represent a major advance in interventional cardiology. Along with the success shown, current DES also present limitations related to the presence of polymer-coating, fixed drug, and dose used. With the ISAR (Individualized Drug-Eluting Stent System to Abrogate Restenosis) project, a DES system has been developed that permits individualized choice of the drug and dose to use for the given patient. The objective of this prospective dose finding study was to assess the feasibility, safety, and efficacy of a polymer-free on-site stent coating with increasing rapamycin doses. [ABSTRACT FROM PUBLISHER] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
